Soleus-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
75
Total Value
1388931935
Accession Number
0001802630-25-000006
Form Type
13F-HR
Manager Name
Soleus-Capital-Management-Lp
Data Enrichment
93% identified
70 identified5 unidentified

Holdings

75 positions • $1.4B total value
Manager:
Search and click to pin securities to the top
Page 2 of 4
INSMED Inc
Shares:274.3K
Value:$20.9M
% of Portfolio:1.5% ($20.9M/$1.4B)
RIGEL PHARMACEUTICALS INC
Shares:1.1M
Value:$20.3M
% of Portfolio:1.5% ($20.3M/$1.4B)
HOLOGIC INC
Shares:302.0K
Value:$18.7M
% of Portfolio:1.3% ($18.7M/$1.4B)
ARGENX SE
Shares:28.9K
Value:$17.1M
% of Portfolio:1.2% ($17.1M/$1.4B)
Merus N.V.
Shares:385.8K
Value:$16.2M
% of Portfolio:1.2% ($16.2M/$1.4B)
Nuvalent, Inc.
Shares:214.4K
Value:$15.2M
% of Portfolio:1.1% ($15.2M/$1.4B)
ANI PHARMACEUTICALS INC
Shares:224.7K
Value:$15.0M
% of Portfolio:1.1% ($15.0M/$1.4B)
EDAP TMS SA
Shares:7.3M
Value:$14.3M
% of Portfolio:1.0% ($14.3M/$1.4B)
Inhibikase Therapeutics, Inc.
Shares:6.3M
Value:$13.9M
% of Portfolio:1.0% ($13.9M/$1.4B)
Evolus, Inc.
Shares:1.1M
Value:$13.0M
% of Portfolio:0.9% ($13.0M/$1.4B)
Pharvaris N.V.
Shares:814.7K
Value:$12.8M
% of Portfolio:0.9% ($12.8M/$1.4B)
Shares:226.2K
Value:$12.5M
% of Portfolio:0.9% ($12.5M/$1.4B)
C4 Therapeutics, Inc.
Shares:7.0M
Value:$11.2M
% of Portfolio:0.8% ($11.2M/$1.4B)
SOLENO THERAPEUTICS INC
Shares:150.0K
Value:$10.7M
% of Portfolio:0.8% ($10.7M/$1.4B)
Kiniksa Pharmaceuticals International, plc
Shares:469.5K
Value:$10.4M
% of Portfolio:0.8% ($10.4M/$1.4B)
Arcellx, Inc.
Shares:153.0K
Value:$10.0M
% of Portfolio:0.7% ($10.0M/$1.4B)
Syndax Pharmaceuticals Inc
Shares:816.6K
Value:$10.0M
% of Portfolio:0.7% ($10.0M/$1.4B)
Orthofix Medical Inc.
Shares:601.9K
Value:$9.8M
% of Portfolio:0.7% ($9.8M/$1.4B)
TANDEM DIABETES CARE INC
Shares:496.0K
Value:$9.5M
% of Portfolio:0.7% ($9.5M/$1.4B)
Scholar Rock Holding Corp
Shares:285.0K
Value:$9.2M
% of Portfolio:0.7% ($9.2M/$1.4B)